{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:42Z","timestamp":1792783302791,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Bursa Uludag University Scientific Research Projects Unit grant","award":["TGA4-2025-2051"],"award-info":[{"award-number":["TGA4-2025-2051"]}],"id":[{"id":"https:\/\/ror.org\/03tg3eb07","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03359-7","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:03:30Z","timestamp":1787987010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Narciclasine reduces proliferation and migration of neuroblastoma cells and decreases FAK\/PI3K pathway activation"],"prefix":"10.1007","volume":"43","author":[{"given":"Ceren","family":"Oy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"Serter Kocoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda","family":"Is\u0131klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Gok Yurtseven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"3359_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"GM Brodeur","year":"2003","unstructured":"Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203\u201316.","journal-title":"Nat Rev Cancer"},{"key":"3359_CR2","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMra0804577","volume":"362","author":"JM Maris","year":"2010","unstructured":"Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362:2202\u201311.","journal-title":"N Engl J Med"},{"key":"3359_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03129-6","volume":"7","author":"B Radic-Sarikas","year":"2017","unstructured":"Radic-Sarikas B, Halasz M, Huber KVM, Winter GE, Tsafou KP, Papamarkou T, Brunak S, Kolch W, Superti-Furga G. Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter. Sci Rep. 2017;7:1\u20138.","journal-title":"Sci Rep"},{"key":"3359_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep18144","volume":"5","author":"S Vella","year":"2015","unstructured":"Vella S, Penna I, Longo L, Pioggia G, Garbati P, Florio T, Rossi F, Pagano A. Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA. Sci Rep. 2015;5:1\u201313.","journal-title":"Sci Rep"},{"key":"3359_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0094-0143(05)70087-2","volume":"27","author":"F Alexander","year":"2000","unstructured":"Alexander F, Neuroblastoma. Urol Clin North Am. 2000;27:383\u201392.","journal-title":"Urol Clin North Am"},{"key":"3359_CR6","doi-asserted-by":"crossref","unstructured":"Liu S, Yin W, Lin Y, Huang S, Xue S, Sun G, Wang C. Metastasis pattern and prognosis in children with neuroblastoma. World J Surg Oncol 2023; 21.","DOI":"10.1186\/s12957-023-03011-y"},{"key":"3359_CR7","doi-asserted-by":"crossref","unstructured":"Qiu B, Matthay KK. Advancing therapy for neuroblastoma. Nat Rev Clin Oncol. 2022; 19:515\u201333. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35614230\/","DOI":"10.1038\/s41571-022-00643-z"},{"key":"3359_CR8","doi-asserted-by":"crossref","unstructured":"Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, Weiss WA, Neuroblastoma. Nat Rev Dis Primers 2016; 2.","DOI":"10.1038\/nrdp.2016.78"},{"key":"3359_CR9","doi-asserted-by":"crossref","unstructured":"Georgiev V, Ivanov I, Pavlov A. Recent Progress in Amaryllidaceae Biotechnology. Molecules 2020; 25.","DOI":"10.3390\/molecules25204670"},{"key":"3359_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.lfs.2018.08.073","volume":"213","author":"JJ Nair","year":"2018","unstructured":"Nair JJ, van Staden J. Cell cycle modulatory effects of Amaryllidaceae alkaloids. Life Sci. 2018;213:94\u2013101.","journal-title":"Life Sci"},{"key":"3359_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1593\/neo.07535","volume":"9","author":"P Dumont","year":"2007","unstructured":"Dumont P, Ingrassia L, Rouzeau S, Ribaucour F, Thomas S, Roland I, Darro F, Lefranc F, Kiss R. The amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and\/or mitochondrial pathways in cancer cells but not in normal fibroblasts. Neoplasia. 2007;9:766\u201376.","journal-title":"Neoplasia"},{"key":"3359_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/med.21253","volume":"33","author":"G Van Goietsenoven","year":"2013","unstructured":"Van Goietsenoven G, Mathieu V, Lefranc F, Kornienko A, Evidente A, Kiss R. Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers. Med Res Rev. 2013;33:439\u201355.","journal-title":"Med Res Rev"},{"key":"3359_CR13","doi-asserted-by":"crossref","unstructured":"Qiu Y, Fang B, Thuy NTT, Li A, Yoo HM, Zheng X, Cho N. Narciclasine suppresses esophageal cancer cell proliferation and migration by inhibiting the FAK signaling pathway. Eur J Pharmacol 2022; 921.","DOI":"10.1016\/j.ejphar.2021.174669"},{"key":"3359_CR14","doi-asserted-by":"crossref","unstructured":"Yuan Y, He X, Li X, Liu Y, Tang Y, Deng H, Shi X. Narciclasine induces autophagy-mediated apoptosis in gastric cancer cells through the Akt\/mTOR signaling pathway. BMC Pharmacol Toxicol 2021; 22.","DOI":"10.1186\/s40360-021-00537-3"},{"key":"3359_CR15","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1055\/s-0042-115034","volume":"82","author":"R F\u00fcrst","year":"2016","unstructured":"F\u00fcrst R. Narciclasine - an Amaryllidaceae Alkaloid with Potent Antitumor and Anti-Inflammatory Properties. Planta Med. 2016;82:1389\u201394.","journal-title":"Planta Med"},{"key":"3359_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.omto.2021.12.025","volume":"24","author":"C Lv","year":"2022","unstructured":"Lv C, Huang Y, Huang R, Wang Q, Zhang H, Jin J, Lu D, Zhou Y, Shen Y, Zhang W, et al. Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells. Mol Ther Oncolytics. 2022;24:340\u201354.","journal-title":"Mol Ther Oncolytics"},{"key":"3359_CR17","doi-asserted-by":"crossref","unstructured":"Deng H, Liu Q, Yu S, Zhong L, Gan L, Gu H, Wang Q, Cheng R, Liu Y, Liu L et al. Narciclasine induces colon carcinoma cell apoptosis by inhibiting the IL-17A\/Act1\/TRAF6\/NF-\u03baB signaling pathway. Genes Dis 2024; 11.","DOI":"10.1016\/j.gendis.2023.03.014"},{"key":"3359_CR18","doi-asserted-by":"crossref","unstructured":"Wang M, Liang L, Wang R, Jia S, Xu C, Wang Y, Luo M, Lin Q, Yang M, Zhou H et al. Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells. Nat Prod Bioprospect 2023; 13.","DOI":"10.1007\/s13659-023-00392-1"},{"key":"3359_CR19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2174\/187152010794728684","volume":"10","author":"L Gillory","year":"2010","unstructured":"Gillory L, Beierle A. Targeting Focal Adhesion Kinase in Neuroblastoma. Anticancer Agents Med Chem. 2010;10:714.","journal-title":"Anticancer Agents Med Chem"},{"key":"3359_CR20","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.4161\/cc.9.5.10936","volume":"9","author":"EA Beierle","year":"2010","unstructured":"Beierle EA, Ma X, Stewart J, Nyberg C, Trujillo A, Cance WG, Golubovskaya VM. Inhibition of Focal Adhesion Kinase Decreases Tumor Growth in Human Neuroblastoma. Cell Cycle. 2010;9:1005.","journal-title":"Cell Cycle"},{"key":"3359_CR21","doi-asserted-by":"publisher","first-page":"1274209","DOI":"10.3389\/fphar.2024.1274209","volume":"15","author":"HH Hu","year":"2024","unstructured":"Hu HH, Wang SQ, Shang HL, Lv HF, Chen BB, Gao SG, Chen XB. Roles and inhibitors of FAK in cancer: current advances and future directions. Front Pharmacol. 2024;15:1274209.","journal-title":"Front Pharmacol"},{"key":"3359_CR22","doi-asserted-by":"publisher","first-page":"107354","DOI":"10.1016\/j.aquatox.2025.107354","volume":"283","author":"TV Nguyen","year":"2025","unstructured":"Nguyen TV, Alfarsi A, Nguyen HT, Davidson G, Lloyd NDR, Kumar A. Metabolic disruptions induced by low concentrations of DMSO in RTgill-W1 fish cells: The importance of solvent controls in in vitro studies. Aquat Toxicol. 2025;283:107354.","journal-title":"Aquat Toxicol"},{"key":"3359_CR23","doi-asserted-by":"crossref","unstructured":"Qiu Y, Fang B, Thuy NTT, Li A, Yoo HM, Zheng X, Cho N. Narciclasine suppresses esophageal cancer cell proliferation and migration by inhibiting the FAK signaling pathway. Eur J Pharmacol 2022; 921.","DOI":"10.1016\/j.ejphar.2021.174669"},{"key":"3359_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2298\/ABS220219021S","volume":"74","author":"J Jovanovi\u0107","year":"2022","unstructured":"Jovanovi\u0107 J, Popovi\u0107 S, Simi\u0107 GS, Jovanovi\u0107 V, Predojevi\u0107 D, Jovanovi\u0107 D, Karad\u017ei\u0107 V. Erianin, a promising agent in the treatment of glioblastoma multiforme triggers apoptosis in U373 and A172 glioblastoma cells. Arch Biol Sci. 2022;74:227\u201334.","journal-title":"Arch Biol Sci"},{"key":"3359_CR25","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.18632\/oncotarget.27096","volume":"10","author":"J Qiao","year":"2019","unstructured":"Qiao J, Rellinger EJ, Kim KW, Powers CM, Lee S, Correa H, Chung DH. Identification of \u03b1-N-catenin as a novel tumor suppressor in neuroblastoma. Oncotarget. 2019;10:5028\u201340.","journal-title":"Oncotarget"},{"key":"3359_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/cbdd.14165","volume":"102","author":"AT Kiddane","year":"2023","unstructured":"Kiddane AT, Roy VC, Kang MJ, Patil MP, Chun BS, Kim G, Do. Anticancer and apoptotic activity in neuroblastoma SK-N-SH using phospholipid extract from bone of Scomberomorus niphonius. Chem Biol Drug Des. 2023;102:424\u201333.","journal-title":"Chem Biol Drug Des"},{"key":"3359_CR27","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1111\/cts.13593","volume":"16","author":"S Serter Kocoglu","year":"2023","unstructured":"Serter Kocoglu S, Oy C, Secme M, Sunay FB. Investigation of the anticancer mechanism of monensin via apoptosis-related factors in SH-SY5Y neuroblastoma cells. Clin Transl Sci. 2023;16:1725\u201335.","journal-title":"Clin Transl Sci"},{"key":"3359_CR28","doi-asserted-by":"crossref","unstructured":"Serter Kocoglu S, Secme M, Oy C, Korkusuz G, Elmas L. Monensin, an Antibiotic Isolated from Streptomyces Cinnamonensis, Regulates Human Neuroblastoma Cell Proliferation via the PI3K\/AKT Signaling Pathway and Acts Synergistically with Rapamycin. Antibiot (Basel) 2023; 12.","DOI":"10.3390\/antibiotics12030546"},{"key":"3359_CR29","doi-asserted-by":"publisher","first-page":"e0127123","DOI":"10.1371\/journal.pone.0127123","volume":"10","author":"PN Harter","year":"2015","unstructured":"Harter PN, Jennewein L, Baumgarten P, Ilina E, Burger MC, Thiepold AL, Tichy J, Z\u00f6rnig M, Senft C, Steinbach JP, et al. Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors. PLoS ONE. 2015;10:e0127123.","journal-title":"PLoS ONE"},{"key":"3359_CR30","doi-asserted-by":"publisher","first-page":"114159","DOI":"10.1016\/j.biopha.2022.114159","volume":"158","author":"MK Shieu","year":"2023","unstructured":"Shieu MK, Ho HY, Lin CC, Lo YS, Chuang YC, Hsieh MJ, Chen MK. Narciclasine suppresses oral cancer metastasis by modulating cathepsin B and extracellular signal\u2013related kinase pathways. Biomed Pharmacother. 2023;158:114159.","journal-title":"Biomed Pharmacother"},{"key":"3359_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/med.21750","volume":"41","author":"A Zafar","year":"2021","unstructured":"Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F, Foster J, Zhou J, Zhang R. Molecular targeting therapies for neuroblastoma: Progress and challenges. Med Res Rev. 2021;41:961\u20131021.","journal-title":"Med Res Rev"},{"key":"3359_CR32","doi-asserted-by":"publisher","first-page":"e31845","DOI":"10.1002\/pbc.31845","volume":"72","author":"W Wei","year":"2025","unstructured":"Wei W, Fader ME, Kushner BH, Cardenas FI, Kramer K, Basu E, Modak S. Pulmonary Toxicity Associated With Concurrent Lorlatinib and Anti-GD2 Monoclonal Antibody Therapy in Patients With Neuroblastoma. Pediatr Blood Cancer. 2025;72:e31845.","journal-title":"Pediatr Blood Cancer"},{"key":"3359_CR33","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2174\/1389201017666160808160513","volume":"17","author":"A Adan","year":"2016","unstructured":"Adan A, Kiraz Y, Baran Y. Cell Proliferation and Cytotoxicity Assays. Curr Pharm Biotechnol. 2016;17:1213\u201321.","journal-title":"Curr Pharm Biotechnol"},{"key":"3359_CR34","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.gendis.2023.03.014","volume":"11","author":"H Deng","year":"2023","unstructured":"Deng H, Liu Q, Yu S, Zhong L, Gan L, Gu H, Wang Q, Cheng R, Liu Y, Liu L, et al. Narciclasine induces colon carcinoma cell apoptosis by inhibiting the IL-17A\/Act1\/TRAF6\/NF-\u03baB signaling pathway. Genes Dis. 2023;11:100938.","journal-title":"Genes Dis"},{"key":"3359_CR35","doi-asserted-by":"crossref","unstructured":"Yuan Y, He X, Li X, Liu Y, Tang Y, Deng H, Shi X. Narciclasine induces autophagy-mediated apoptosis in gastric cancer cells through the Akt\/mTOR signaling pathway. BMC Pharmacol Toxicol 2021; 22.","DOI":"10.1186\/s40360-021-00537-3"},{"key":"3359_CR36","doi-asserted-by":"crossref","unstructured":"Wang M, Liang L, Wang R, Jia S, Xu C, Wang Y, Luo M, Lin Q, Yang M, Zhou H et al. Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells. Nat Prod Bioprospect 2023; 13.","DOI":"10.1007\/s13659-023-00392-1"},{"key":"3359_CR37","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1096\/fj.10-162263","volume":"24","author":"G Van Goietsenoven","year":"2010","unstructured":"Van Goietsenoven G, Hutton J, Becker JP, Lallemand B, Robert F, Lefranc F, Pirker C, Vandenbussche G, Van Antwerpen P, Evidente A, et al. Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas. FASEB J. 2010;24:4575\u201384.","journal-title":"FASEB J"},{"key":"3359_CR38","doi-asserted-by":"crossref","unstructured":"Gomez RL, Woods LM, Ramachandran R, Abou Tayoun AN, Philpott A, Ali FR. Super-enhancer associated core regulatory circuits mediate susceptibility to retinoic acid in neuroblastoma cells. Front Cell Dev Biol 2022; 10.","DOI":"10.3389\/fcell.2022.943924"},{"key":"3359_CR39","doi-asserted-by":"crossref","unstructured":"Ponzoni M, Bachetti T, Corrias MV, Brignole C, Pastorino F, Calarco E, Bensa V, Giusto E, Ceccherini I, Perri P. Recent advances in the developmental origin of neuroblastoma: an overview. J Exp Clin Cancer Res 2022; 41.","DOI":"10.1186\/s13046-022-02281-w"},{"key":"3359_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2741\/e257","volume":"3","author":"EA Beierle","year":"2011","unstructured":"Beierle EA. MYCN, Neuroblastoma and Focal Adhesion Kinase (FAK). Front Biosci. 2011;3:421.","journal-title":"Front Biosci"},{"key":"3359_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40360-021-00537-3","volume":"22","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, He X, Li X, Liu Y, Tang Y, Deng H, Shi X. Narciclasine induces autophagy-mediated apoptosis in gastric cancer cells through the Akt\/mTOR signaling pathway. BMC Pharmacol Toxicol. 2021;22:70.","journal-title":"BMC Pharmacol Toxicol"},{"key":"3359_CR42","doi-asserted-by":"publisher","first-page":"108482","DOI":"10.1016\/j.mbs.2020.108482","volume":"330","author":"A Gnerucci","year":"2020","unstructured":"Gnerucci A, Faraoni P, Sereni E, Ranaldi F. Scratch assay microscopy: A reaction\u2013diffusion equation approach for common instruments and data. Math Biosci. 2020;330:108482.","journal-title":"Math Biosci"},{"key":"3359_CR43","doi-asserted-by":"publisher","first-page":"e4007","DOI":"10.1002\/cbf.4007","volume":"42","author":"L Khalef","year":"2024","unstructured":"Khalef L, Lydia R, Filicia K, Moussa B. Cell viability and cytotoxicity assays: Biochemical elements and cellular compartments. Cell Biochem Funct. 2024;42:e4007.","journal-title":"Cell Biochem Funct"},{"key":"3359_CR44","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1186\/s12967-025-07368-4","volume":"23","author":"JY Sung","year":"2025","unstructured":"Sung JY, Yoo HE, Kim S, Yu S, Park SW, Lim GE, Lee B, Il, Yoon K, Kim HJ, Ye SK, et al. Narciclasine as a potential therapeutic agent to overcome EGFR-TKI resistance in non-small cell lung cancer. J Transl Med. 2025;23:1380.","journal-title":"J Transl Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03359-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03359-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03359-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:58Z","timestamp":1792096918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03359-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3359"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03359-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"261"}}